Shareholders' Equity (Details) $ / shares in Units, $ in Thousands |
1 Months Ended | 2 Months Ended | 12 Months Ended | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 20, 2021 |
Jul. 08, 2020
USD ($)
$ / shares
shares
|
Jun. 12, 2020
$ / shares
shares
|
Mar. 09, 2020
USD ($)
$ / shares
shares
|
Feb. 12, 2020 |
Feb. 10, 2020
USD ($)
$ / shares
shares
|
Jan. 09, 2020
USD ($)
$ / shares
shares
|
May 10, 2019 |
Apr. 04, 2019
USD ($)
$ / shares
shares
|
Aug. 16, 2021
USD ($)
$ / shares
shares
|
Mar. 31, 2021
USD ($)
shares
|
Apr. 28, 2020
₪ / shares
shares
|
Dec. 31, 2019
shares
|
Sep. 30, 2019
shares
|
May 22, 2019
USD ($)
$ / shares
shares
|
Jan. 18, 2019
USD ($)
$ / shares
shares
|
Mar. 31, 2021
USD ($)
shares
|
May 31, 2020
USD ($)
$ / shares
shares
|
Dec. 31, 2021
₪ / shares
shares
|
Dec. 31, 2020
USD ($)
shares
|
Dec. 31, 2019
USD ($)
shares
|
Dec. 31, 2020
₪ / shares
|
Nov. 28, 2013
₪ / shares
shares
|
|
| Shareholders' Equity (Details) [Line Items] | |||||||||||||||||||||||
| Stockholders equity change In ratio description | (1) ADS representing two (2) ordinary shares to a new ratio of one (1) ADS representing thirty (30) ordinary shares. For ADS holders, the ratio change had the same effect as a one-for-fifteen reverse ADS split. All ADS and per ADS data in the financial statements and their related notes have been retroactively adjusted for all periods presented to reflect the ratio change. | ||||||||||||||||||||||
| Sold an aggregate shares | 356,803 | 356,803 | |||||||||||||||||||||
| Ordinary shares issued | 20,250,000 | 996,690 | 19,934,355 | 31,000,020 | |||||||||||||||||||
| Aggregate purchase price (in Dollars) | $ | $ 3,200 | $ 6,000 | $ 2,350 | ||||||||||||||||||||
| Issuance cost (in Dollars) | $ | $ 414 | $ 540 | $ 428 | ||||||||||||||||||||
| Ordinary shares issued | 30 | ||||||||||||||||||||||
| Aggregate shares | 22,278,540 | ||||||||||||||||||||||
| Reduced exercise price (in Dollars per share) | $ / shares | $ 3.25 | ||||||||||||||||||||||
| Gross proceeds (in Dollars) | $ | $ 3,400 | $ 1,012 | $ 2,400 | $ 1,550 | $ 75 | $ 115 | |||||||||||||||||
| Issue of new unregistered warrants | 852,750 | 22,278,540 | |||||||||||||||||||||
| Deemed dividend (in Dollars) | $ | $ 715 | ||||||||||||||||||||||
| Securities purchase agreement, description | the Company completed a public offering with certain institutional investors pursuant to which the Company issued and sold (i) 1,825,000 units, each unit consisting of one ADS, and one warrant to purchase one ADS, at a price of USD 1.50 per unit, and (ii) 1,508,334 pre-funded units each pre-funded unit consisting of one pre-funded warrant to purchase one ADS and one warrant, at a price of USD 1.49 per pre-funded unit. | ||||||||||||||||||||||
| Gross proceeds from offering (in Dollars) | $ | $ 5,000 | ||||||||||||||||||||||
| Expiring date | Feb. 10, 2025 | ||||||||||||||||||||||
| Increase authorized capital | 1,000,000,000 | ||||||||||||||||||||||
| Par value (in New Shekels per share) | ₪ / shares | ₪ 0.25 | ₪ 0.25 | ₪ 0.25 | ₪ 0.25 | |||||||||||||||||||
| Stock issuance agreement, description | On June 12, 2020, the Company completed a registered direct offering with certain institutional and accredited investors pursuant to which it sold an aggregate of 3,902,440 ADSs at a purchase price of $2.05 per ADS for aggregate gross proceeds of approximately $8,000 prior to deducting the placement agent’s fees and estimated offering expenses payable by the Company. | ||||||||||||||||||||||
| Aggregate number of ADS percentage | 7.50% | 7.50% | |||||||||||||||||||||
| Exercise price per ADS (in Dollars per share) | $ / shares | $ 2.5 | $ 2.5 | $ 2 | ||||||||||||||||||||
| Warrants to purchase aggregate ADS shares | 127,913 | ||||||||||||||||||||||
| Exercise price (in Dollars per share) | $ / shares | $ 2.5 | ||||||||||||||||||||||
| Ordinary shares | 1,350,000 | ||||||||||||||||||||||
| Total consideration amount (in Dollars) | $ | $ 2,744 | $ 2,744 | |||||||||||||||||||||
| Fair value amount (in Dollars) | $ | $ 68 | $ 68 | |||||||||||||||||||||
| Purchase agreement description | On August 16, 2021, the Company completed a registered direct offering with an institutional investor pursuant to which it sold (i) 57,000,000 ordinary shares represented by 1,900,000 ADSs, and (ii) a pre-funded warrant to purchase 93,000,000 ordinary shares represented by 3,100,000 ADSs at an offering price of $2.00 per ADS and $1.999 per pre-funded warrant, for aggregate gross proceeds of approximately $10,000 (without taking into account any proceeds from any future exercises of warrants issued in the concurrent private placement), before deducting the placement agent’s fees and other estimated offering expenses payable by the Company. The Company has also sold to the investor, in a concurrent private placement, unregistered warrants to purchase up to an aggregate of 5,000,000 ADSs. The warrants have an exercise price of $ 2.00 per ADS and are exercisable at any time upon issuance and will expire three years following the effectiveness of an initial resale registration statement registering the ADSs issuable upon the exercise of the warrants. As of the financial statements date, the Company received a total of $ 9,997 and issued 57,000,000 ordinary shares represented by 1,900,000 ADSs and 93,000,000 ordinary shares represented by 3,100,000 ADSs following the exercise of the pre-funded warrants (issuance expenses were $1,307). 17. On December 20, 2021, the Company entered into a warrant exercise agreement (the “Exercise Agreement”) with an institutional investor who is the holder of certain existing warrants to purchase Company’s ordinary shares, par value NIS 0.25 per share, represented by ADSs issued by the Company in a registered direct offering consummated in August 2021. | ||||||||||||||||||||||
| Total received amount (in Dollars) | $ | $ 9,997 | ||||||||||||||||||||||
| Ordinary shares | 93,000,000 | ||||||||||||||||||||||
| Issuance expenses amount (in Dollars) | $ | $ 1,307 | ||||||||||||||||||||||
| Exercise agreement description | Pursuant to the Exercise Agreement, the holder agreed to exercise in cash its warrants to purchase up to an aggregate of 150,000,000 Ordinary Shares represented by 5,000,000 ADSs having an exercise price of $2.00 per ADS, at an exercise price of $2.00 per ADS, for gross proceeds to the Company of $10 million, prior to deducting placement agent fees and offering expenses (which amounted to $0.98 million). Under the Exercise Agreement, the Company also agreed to issue to the holder new unregistered warrants to purchase up to 180,000,000 Ordinary Shares represented by 6,000,000 ADSs (the “Private Placement Warrants”). The Private Placement Warrants will be immediately exercisable, will expire five years following the effectiveness of an initial resale registration statement registering the ADSs issuable upon the exercise of the warrants, and have an exercise price of $2.00 per ADS. Pursuant to the terms of the Exercise Agreements, the holder agreed to exercise the warrants while receiving a-120% warrants coverage, thereby creating a benefit to this warrant holder. As such, the Company recorded a deemed dividend in the amount of $ 2,590. | ||||||||||||||||||||||
| ADS [Member] | |||||||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||||||||||||
| Sold an aggregate shares | 328,205 | 1,500,000 | 149,206 | ||||||||||||||||||||
| Ordinary shares issued | 675,000 | 1,033,334 | |||||||||||||||||||||
| Warrants to purchase additional shares | 149,206 | ||||||||||||||||||||||
| Warrant exercise price (in Dollars per share) | $ / shares | $ 19.5 | ||||||||||||||||||||||
| Purchase aggregate warrant | 328,205 | 1,500,000 | 7,460 | ||||||||||||||||||||
| Exercise prices (in Dollars per share) | $ / shares | $ 2.5 | $ 1.875 | $ 12.9 | $ 4 | |||||||||||||||||||
| Aggregate warrant purchased | 292,683 | 16,410 | 5,000,000 | 75,000 | |||||||||||||||||||
| Aggregate shares | 742,618 | ||||||||||||||||||||||
| Issue of new unregistered warrants | 1,705,000 | 1,951,220 | |||||||||||||||||||||
| Exercise price subject to adjustment (in Dollars per share) | $ / shares | $ 3.45 | ||||||||||||||||||||||
| Compensation warrant exercisable | 250,000 | ||||||||||||||||||||||
| Share price (in Dollars per share) | $ / shares | $ 1.5 | $ 1.5 | |||||||||||||||||||||
| Exercise price per ADS (in Dollars per share) | $ / shares | $ 2 | ||||||||||||||||||||||
| Ordinary shares | 1,900,000 | 35,000 | 1,697,561 | ||||||||||||||||||||
| Ordinary shares | 3,100,000 | ||||||||||||||||||||||
| ADS [Member] | Minimum [Member] | |||||||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||||||||||||
| Exercise prices (in Dollars per share) | $ / shares | 12.9 | ||||||||||||||||||||||
| ADS [Member] | Maximum [Member] | |||||||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||||||||||||
| Exercise prices (in Dollars per share) | $ / shares | $ 78.75 | ||||||||||||||||||||||
| Ordinary Shares [Member] | |||||||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||||||||||||
| Sold an aggregate shares | 9,846,156 | ||||||||||||||||||||||
| Ordinary shares issued | 9,846,156 | 45,000,000 | 4,476,192 | 1,350,000 | 996,690 | ||||||||||||||||||
| Warrants to purchase additional shares | 4,476,192 | ||||||||||||||||||||||
| Ordinary shares issued | 492,308 | 45,000,000 | 223,810 | 2,500,000 | |||||||||||||||||||
| Ordinary shares issued | 2,250,000 | ||||||||||||||||||||||
| Aggregate shares | 1,050,000 | ||||||||||||||||||||||
| Gross proceeds (in Dollars) | $ | $ 100 | $ 72 | |||||||||||||||||||||
| Ordinary shares | 57,000,000 | 1,050,000 | 50,926,830 | ||||||||||||||||||||
| Private Placement Warrants [Member] | ADS [Member] | |||||||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||||||||||||
| Issue of new unregistered warrants | 742,618 | ||||||||||||||||||||||